Skip to main content

RELACION ENTRE ERALPHA, ERBETA Y GPER EN LAS CELULAS BETA DEL PANCREAS Y SU PAPEL EN LA REGULACION DE LOS CANALES DE POTASIO Y LA APOPTOSIS INDUCIDA POR ESTROGENOS AMBIENTALES

PID2020-117294RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

The role of estrogen receptors on ion channel regulation, electrical activity and insulin secretion in the human pancreatic β-cell line EndoC-βH1

  • Sempere-Navarro, Roberto
The estrogen response pathway consists of three different estrogen receptors: estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and the G-protein coupled estrogen receptor (GPER). Activation of these receptors by the naturally occurring hormone 17β-estradiol (E2) results in a plethora of actions in virtually every organ. Exogenous ligands, including endocrine disruptors such as bisphenol A (BPA), can disrupt these responses by interfering with estrogen receptor-initiated pathways. This contributes to the disruption of hormone actions. In pancreatic β-cells, ERα has been associated with cell survival, insulin biosynthesis, and the preservation of functional β-cell mass, whereas ERβ has been linked to ion-channel regulation, electrical excitability, and insulin secretion. In mouse β-cells, prolonged exposure to BPA or selective ERβ activation with diarylpropionitrile (DPN) reduces voltage-dependent K+ currents, while E2 does not reproduce this effect. However, it remained unclear whether this ERβ-associated electrical remodeling is conserved in human β-cells. Moreover, despite the established role of ERα in β-cell survival and insulin biosynthesis, its contribution to voltage-dependent ion-channel activity and action-potential firing in human β-cells had received little attention. This thesis therefore investigated whether the BPA-induced K+ current phenotype described in mouse β-cells is reproduced in the human EndoC-βH1 cell line and examined how selective activation of ERα and ERβ by propylpyrazoletriol (PPT) and DPN, respectively, affects ion channel activity, electrical excitability, insulin content and insulin secretion. Chronic exposure to a low, environmentally relevant dose of BPA (1 nM, 48 h) reduced the total macroscopic K+ current of EndoC-βH1 cells. The effect became detectable after 18 h, it was reproduced by the ERβ agonist DPN — but not by E2, PPT or the GPER agonist G-1 — and was abolished by the ERβ antagonist PHTPP, yet the ERα antagonist MPP was without effect. Pharmacological dissection showed that BPA reduced the delayed-rectifier Kᵥ component (compatible with Kᵥ2.1/Kᵥ2.2) while leaving the large-conductance BK current unchanged, indicating a slow, ERβ-dependent and likely transcriptional remodeling of the β-cell K+ conductance. This provides the first direct test in a human β-cell of a phenomenon previously described only in rodents. PPT increased macroscopic Ca2+ current density and caused a small depolarizing shift in apparent activation, without significantly modifying Na+ or K+ currents. DPN reduced peak Na+ current without changing activation or steady-state inactivation, and decreased total K+ current without significantly altering total Ca2+ current. Both PPT and DPN depolarized the resting membrane potential, increased firing frequency, broadened the action potential and reduced its amplitude. These electrical changes translated only modestly into secretory output: none of the ligands (E2, BPA, PPT, DPN) significantly altered insulin content or absolute secretion, but basal secretion normalized to content was significantly reduced by DPN and E2. Overall, ERα and ERβ ligands remodel excitability in a human β-cell model through distinct ion-channel mechanisms, while BPA engages an ERβ-associated pathway that reduces Kv-enriched current. These electrical effects do not necessarily translate into increased insulin output, highlighting the importance of ligand identity, receptor context and exposure duration when evaluating estrogenic actions in the human β-cell.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells

  • Babiloni-Chust, Ignacio
  • Dos Santos, Reinaldo S.
  • Medina-Gali, Regla M.
  • Perez-Serna, Atenea A.
  • Encinar, José A.
  • Martinez-Pinna, Juan
  • Gustafsson, Jan-Ake
  • Marroquí, Laura
  • Nadal, Ángel
  • Martinez-Pinna, Juan|||/items/17fe7946-bb18-45cf-bd71-482acc1cec7b
  • Medina-Gali, Regla M.|||/items/5fbc80d1-40a9-434e-ac52-25199b5f124c
17β-estradiol protects pancreatic β-cells from apoptosis via the estrogen receptors ERα, ERβ and GPER. Conversely, the endocrine disruptor bisphenol-A (BPA), which exerts multiple effects in this cell type via the same estrogen receptors, increased basal apoptosis. The molecular-initiated events that trigger these opposite actions have yet to be identified. We demonstrated that combined genetic downregulation and pharmacological blockade of each estrogen receptor increased apoptosis to a different extent. The increase in apoptosis induced by BPA was diminished by the pharmacological blockade or the genetic silencing of GPER, and it was partially reproduced by the GPER agonist G1. BPA and G1-induced apoptosis were abolished upon pharmacological inhibition, silencing of ERα and ERβ, or in dispersed islet cells from ERβ knockout (BERKO) mice. However, the ERα and ERβ agonists PPT and DPN, respectively, had no effect on beta cell viability. To exert their biological actions, ERα and ERβ form homodimers and heterodimers. Molecular dynamics simulations together with proximity ligand assays and coimmunoprecipitation experiments indicated that the interaction of BPA with ERα and ERβ as well as GPER activation by G1 decreased ERαβ heterodimers. We propose that ERαβ heterodimers play an antiapoptotic role in beta cells and that BPA- and G1-induced decreases in ERαβ heterodimers lead to beta cell apoptosis. Unveiling how different estrogenic chemicals affect the crosstalk among estrogen receptors should help to identify diabetogenic endocrine disruptors.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

The pancreatic β-cell in ageing: Implications in age-related diabetes

  • Tudurí, Eva
  • Soriano, Sergi
  • Almagro, Lucía
  • Montanya, Eduard
  • Alonso Magdalena, Paloma
  • Nadal, Ángel
  • Quesada, Iván
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
  • Tudurí, Eva|||/items/ed03c763-6d0f-4b5a-a720-80238ac8cc4e
The prevalence of type 2 diabetes (T2D) and impaired glucose tolerance (IGT) increases with ageing. T2D generally results from progressive impairment of the pancreatic islets to adapt β-cell mass and function in the setting of insulin resistance and increased insulin demand. Several studies have shown an age-related decline in peripheral insulin sensitivity. However, a precise understanding of the pancreatic β-cell response in ageing is still lacking. In this review, we summarize the age-related alterations, adaptations and/or failures of β-cells at the molecular, morphological and functional levels in mouse and human. Age-associated alterations include processes such as β-cell proliferation, apoptosis and cell identity that can influence β-cell mass. Age-related changes also affect β-cell function at distinct steps including electrical activity, Ca2+ signaling and insulin secretion, among others. We will consider the potential impact of these alterations and those mediated by senescence pathways on β-cells and their implications in age-related T2D. Finally, given the great diversity of results in the field of β-cell ageing, we will discuss the sources of this heterogeneity. A better understanding of β-cell biology during ageing, particularly at older ages, will improve our insight into the contribution of β-cells to age-associated T2D and may boost new therapeutic strategies.